You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of patients with SAA treated with or without MSCs

From: Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia

Characteristics MSC Group (n = 9) Control Group (n = 9) P
Median age, years (range) 4 (1-10) 5 (3-9) 0.438
Gender, male / female 3 / 6 5 / 4 0.637
Type of AA
 SAA, n (%) 2 (22%) 4 (44%) 0.620
 vSAA, n (%) 7 (78%) 5 (56%)  
Median duration from diagnosis to ATG treatment, days (range) 26 (9-159) 39 (26-179) 0.281
Median WBC, ×109/L (range) 1.84 (0.57-4.79) 2.60 (0.65-5.23) 0.699
Median HGB, g/L (range) 76 (47-117) 65 (47-105) 0.475
Median PLT,×109/L (range) 10 (1-18) 8 (4-19) 0.500
Median ANC,×109/L (range) 0.07 (0-0.36) 0.13 (0.01-0.41) 0.229
Median ARC,×109/L (range) 5.4 (2.6-32.8) 4.5 (2.2-17.0) 0.587
Median percentage of CD3 + CD4+ T-cell lymphocytes, % (range) 39.6 (35.7-42.9) 43.2 (28.4-73.0) 0.401
Median percentage of CD3 + CD8+ T-cell lymphocytes, % (range) 25.6 (14.1-35.1) 25.8 (9.4-35.2) 0.885
Median percentage of Tregs, % (range)a 7.0 (3.5-9.4) 6.7 (2.2-16.8) 0.763
Median percentage of mature lymphocytes in BM, % (range) 94.1 (44.5-98.5) 87.9 (36.2-97.7) 0.306
  1. Abbreviations: AA Aplastic anemia, SAA Severe aplastic anemia, vSAA Very severe aplastic anemia, ATG Antithymocyte globulin, WBC White blood cell, HGB Hemoglobin, PLT Platelet, ANC Absolute neutrophil count, ARC Absolute reticulocyte count, Tregs CD4 + CD25 + CD127dim regulatory T cells, BM Bone marrow
  2. aThe normal range of Tregs is 5-10%